BK
77
2
HSY
50
5
ADT
48
2
EXPD
48
-2
EXC
53
3
FIS
73
11
MSI
47
-2
AZO
46
-2
C
85
3
HBAN
82
2
GWW
65
3
D
45
4
KIM
56
5
OKE
64
-3
IFF
62
5
AEE
58
3
MAS
63
3
PM
56
2
ES
50
3
AN
52
2
BK
77
2
HSY
50
5
ADT
48
2
EXPD
48
-2
EXC
53
3
FIS
73
11
MSI
47
-2
AZO
46
-2
C
85
3
HBAN
82
2
GWW
65
3
D
45
4
KIM
56
5
OKE
64
-3
IFF
62
5
AEE
58
3
MAS
63
3
PM
56
2
ES
50
3
AN
52
2
Financhill
Back

Columbia Seligman Premium Technology Growth Fund Vs. Travere Therapeutics, Inc. Industry Stock Comparison

Sell
50

STK
Columbia Seligman Premium Technology Growth Fund

Last Price:
$37.21
Seasonality Move:
0.87%
Buy
80

TVTX
Travere Therapeutics, Inc.

Last Price:
$40.3200
Seasonality Move:
33.23%
Sell
50
Columbia Seligman Premium Technology Growth Fund (STK) is a Sell

Is Columbia Seligman Premium Technology Growth Fund a Buy, Sell or Hold?

  • The current Columbia Seligman Premium Technology Growth Fund [STK] share price is $37.20. The Score for STK is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • STK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
80
Travere Therapeutics, Inc. (TVTX) is a Buy

Is Travere Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Travere Therapeutics, Inc. [TVTX] share price is $40.2800. The Score for TVTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

STK Stock Price Chart

What is Columbia Seligman Premium Technology Growth Fund's stock price today?

  • The Columbia Seligman Premium Technology Growth Fund share price today is $37.20
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and STK is experiencing slight buying pressure.

TVTX Stock Price Chart

What is Travere Therapeutics, Inc.'s stock price today?

  • The Travere Therapeutics, Inc. share price today is $40.2800
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight buying pressure.

STK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.97 Buy
Relative Strength Index (14 RSI): 55.81 Buy
Chaikin Money Flow: 11096 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.68 - 37.44) Buy
Bollinger Bands (100): (32.53 - 37.57) Buy

TVTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.67 Buy
Relative Strength Index (14 RSI): 69.35 Buy
Chaikin Money Flow: 1508490 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.0318 - 36.4718) Buy
Bollinger Bands (100): (20.7309 - 34.2909) Buy

STK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.86 Buy
20-day SMA: 36.57 Buy
50-day SMA: 36.87 Buy
200-day SMA: 32 Buy
8-day EMA: 25.96 Buy
20-day EMA: 14.22 Buy
50-day EMA: 6.53 Buy
200-day EMA: 1.76 Buy

TVTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.7 Buy
20-day SMA: 35.23 Buy
50-day SMA: 33.43 Buy
200-day SMA: 22.2 Buy
8-day EMA: 28.52 Buy
20-day EMA: 16.32 Buy
50-day EMA: 7.67 Buy
200-day EMA: 2.09 Buy

Columbia Seligman Premium Technology Growth Fund Earnings Growth & STK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.

Columbia Seligman Premium Technology Growth Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Travere Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):